Endurance Wealth Management, Inc. - REGULUS THERAPEUTICS ownership

REGULUS THERAPEUTICS's ticker is and the CUSIP is 7915K2000. A total of 1 filers reported holding REGULUS THERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of REGULUS THERAPEUTICS
ValueSharesWeighting
Q2 2023$06750.0%0.00%
Q1 2023$0
-100.0%
6750.0%0.00%
Q4 2022$1
-99.9%
6750.0%0.00%
Q3 2022$1,000
-50.0%
6750.0%0.00%
Q2 2022$2,0006750.00%
Other shareholders
REGULUS THERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
Endurance Wealth Management, Inc. 675$2,0000.00%
View complete list of REGULUS THERAPEUTICS shareholders